Skip to main content
. 2021 Dec 1;12:723271. doi: 10.3389/fimmu.2021.723271

Figure 1.

Figure 1

Scheme of the study workflow. LIHC, liver hepatocellular carcinoma; DEGs: differentially expressed genes; LASSO, the least absolute shrinkage and selection operator; ROC, receiver operating characteristic; DCA, decision curve analysis; TMB, tumor mutational burden; TICs, tumor-infiltrating immune cells; ICIs, immune checkpoint inhibitors (PD1, PD-L1, and CTLA4).